Session Details

Hot Line: Late Breaking Clinical Trials 2
28 Aug 11:00 - 12:48 Miscellaneous Hot Line Barcelona - Main Auditorium
Chairpersons: Stephan ACHENBACH (Erlangen, Germany), Sarah Catherine CLARKE (Cambridge, United Kingdom)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
11:00 SPYRAL HTN OFF-MED Study 
11:10 Discussant review: SPYRAL HTN OFF-MED StudyBryan WILLIAMS (London, United Kingdom)
11:15 Panel discussion 
11:18 Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE TrialMichael D EZEKOWITZ (Villanova, United States of America)
11:28 Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE TrialJens Cosedis NIELSEN (Aarhus N, Denmark)
11:33 Panel discussion. 
11:36 An international multicenter clustered randomized trial to IMProve treatment with oral AntiCoagulanTs in Atrial FibrilationChristopher B GRANGER (Durham, United States of America)
11:46 Discussant review: An international multicenter clustered randomized trial to IMProve treatment with oral AntiCoagulanTs in Atrial FibrilationPaulus KIRCHHOF (Birmingham, United Kingdom)
11:51 Panel discussion. 
11:54 The Viborg Vascular randomised screening trialJes LINDHOLT (Odense, Denmark)
12:04 Discussant review: The Viborg Vascular randomised screening trial 
12:09 Panel discussion. 
12:12 Impact of a single or two dose regimen of inclisiran, a novel siRNA inhibitor to PCSK9 on time averaged reductions in LDL-C over 1 year. ORION 1Kausik K RAY (London, United Kingdom)
12:22 Discussant review: Impact of a single or two dose regimen of inclisiran, a novel siRNA inhibitor to PCSK9 on time averaged reductions in LDL-C over 1 year. ORION 1Philip BARTER (Sydney, Australia)
12:27 Panel discussion. 
12:30 DETermination of the role of OXygen in suspected Acute Myocardial InfarctionRobin HOFMANN (Stockholm, Sweden)
12:40 Discussant review: DETermination of the role of OXygen in suspected Acute Myocardial InfarctionDavid NEWBY (Edinburgh, United Kingdom)
12:45 Panel discussion. 

Who we are

What we do

How we work

More ESC